Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.5805EUR
−122.04 MEUR
280.14 MEUR
47.36 M
About Cardlytics, Inc. Common Stock
Sector
Industry
CEO
Amit Gupta
Website
Headquarters
Atlanta
Founded
2008
FIGI
BBG00K8FJXY3
Cardlytics, Inc. engages in the business of operating an advertising platform which includes online, mobile applications, email, and various real-time notifications. It operates under the Cardlytics and Bridg Platforms. The Cardlytics Platform segment focuses on the United States and the United Kingdom, which represents proprietary advertising channels. The Bridg Platform segment is involved in utilizing POS data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing in a privacy protected manner. The company was founded by Scott David Grimes, Lynne Marie Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on DUS exchange CARDLYTICS INC DL-,0001 stocks are traded under the ticker CYX.
We've gathered analysts' opinions on CARDLYTICS INC DL-,0001 future price: according to them, CYX price has a max estimate of 4.62 EUR and a min estimate of 3.24 EUR. Watch CYX chart and read a more detailed CARDLYTICS INC DL-,0001 stock forecast: see what analysts think of CARDLYTICS INC DL-,0001 and suggest that you do with its stocks.
Yes, you can track CARDLYTICS INC DL-,0001 financials in yearly and quarterly reports right on TradingView.
CARDLYTICS INC DL-,0001 is going to release the next earnings report on Nov 6, 2024. Keep track of upcoming events with our Earnings Calendar.
CYX earnings for the last quarter are −0.08 EUR per share, whereas the estimation was −0.43 EUR resulting in a 80.43% surprise. The estimated earnings for the next quarter are −0.51 EUR per share. See more details about CARDLYTICS INC DL-,0001 earnings.
CARDLYTICS INC DL-,0001 revenue for the last quarter amounts to 65.01 M EUR, despite the estimated figure of 70.39 M EUR. In the next quarter, revenue is expected to reach 51.89 M EUR.
CYX net income for the last quarter is −3.97 M EUR, while the quarter before that showed −22.50 M EUR of net income which accounts for 82.33% change. Track more CARDLYTICS INC DL-,0001 financial stats to get the full picture.
No, CYX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 5, 2024, the company has 434.00 employees. See our rating of the largest employees — is CARDLYTICS INC DL-,0001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CARDLYTICS INC DL-,0001 EBITDA is −29.04 M EUR, and current EBITDA margin is −11.05%. See more stats in CARDLYTICS INC DL-,0001 financial statements.
Like other stocks, CYX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CARDLYTICS INC DL-,0001 stock right from TradingView charts — choose your broker and connect to your account.